Urovalve, a medical device company located in the Enterprise Development Center at NJIT, has appointed Bent Johnsen as European managing director. The company develops superior products for urinary flow and control. >>

Five technology-based high-tech ventures that have achieved success in the health care field with the assistance of NJIT’s Enterprise Development Center (EDC) are the recipients of more than a million dollars in funding awarded in 2009 and 2010 under the federal program “Qualifying Therapeutic Discovery Project Grants for the State of New Jersey.” >>

Urovalve, a medical device company located in the NJIT Enterprise Development Center, has announced that President and CEO Harvey Homan PhD has been appointed to an advisory panel for urology and small business at the Center for Scientific Review (CSR) a division of the National Institutes of Health (NIH). >>

A new and innovative technology company participating in the Enterprise Development Center program at New Jersey Institute of Technology (NJIT) has received two awards for its promising achievements.  Last week, Urovalve, Inc., a small startup medical device company, participated in the SmartStart Venture Forum in Albany, and received the best presentation prize.  >>

A new and innovative technology company participating in the Enterprise Development Center program at NJIT has received two awards for their promising achievements. Last week, Urovalve, Inc., a small, upstart medical device company, participated in the SmartStart Venture Forum in Albany, and received the best presentation prize. This week, the company participated in the "Bio-Life-Tech Conference" in Baltimore and received an award for the company most likely to receive funding. >>

Two companies from the Enterprise Development Center (EDC) at New Jersey Institute of Technology (NJIT) won prominent business awards at the New Jersey Technology Council’s (NJTC) 2004 Venture Fair held at the Liberty Science Center. The awards recognize new companies whose products show innovation and promise. >>